Literature DB >> 6696872

Pharmacokinetics of oral acyclovir (Zovirax) in the eye.

S O Hung, A Patterson, P J Rees.   

Abstract

Patients due for cataract extraction received 5 doses of 400 mg acyclovir (Zovirax) orally during the 24 hours prior to surgery. Aqueous humour levels of acyclovir (mean 3.26 microM) were well above the normal ED50 range for herpes simplex virus type 1, and showed a significant correlation with plasma concentrations (mean 8.74 microM). There was also a correlation between the age of the patient and the concentration of acyclovir in the plasma. Oral acyclovir was well tolerated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6696872      PMCID: PMC1040285          DOI: 10.1136/bjo.68.3.192

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

3.  Herpetic iritis: demonstration of virus in the anterior chamber by fluorescent antibody techniques and electron microscopy.

Authors:  H E Kaufman; A Kanai; E D Ellison
Journal:  Am J Ophthalmol       Date:  1971-02       Impact factor: 5.258

4.  Symposium on certain forms of infective kerato-uveitis or uveitis. I. An approach to the problem, and the technique of anterior chamber tap.

Authors:  B R Jones; A Patterson; N S Rice
Journal:  Trans Ophthalmol Soc U K       Date:  1969

5.  Electron microscope observation of herpes-like particles in the iris.

Authors:  R Witmer; T Iwamoto
Journal:  Arch Ophthalmol       Date:  1968-03

6.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

7.  Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.

Authors:  C S Crumpacker; L E Schnipper; J A Zaia; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

8.  A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine].

Authors:  R P Quinn; P de Miranda; L Gerald; S S Good
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

9.  Acyclovir and idoxiuridine treatment of herpes simplex keratitis--a double blind clinical study.

Authors:  A Klauber; E Ottovay
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-10

10.  Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers.

Authors:  B R Jones; D J Coster; P N Fison; G M Thompson; L M Cobo; M G Falcon
Journal:  Lancet       Date:  1979-02-03       Impact factor: 79.321

View more
  17 in total

1.  A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis.

Authors:  S M Porter; A Patterson; P Kho
Journal:  Br J Ophthalmol       Date:  1990-05       Impact factor: 4.638

Review 2.  Ocular surgery after herpes simplex and herpes zoster keratitis.

Authors:  Piotr Kanclerz; Jorge L Alio
Journal:  Int Ophthalmol       Date:  2020-09-10       Impact factor: 2.031

Review 3.  Update on Herpes simplex keratitis management.

Authors:  Daniel Sibley; Daniel F P Larkin
Journal:  Eye (Lond)       Date:  2020-08-25       Impact factor: 3.775

4.  The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin.

Authors:  M Halberstadt; M Machens; K-A Gahlenbek; M Böhnke; J G Garweg
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

5.  Self-Retained Amniotic Membrane Combined With Antiviral Therapy for Herpetic Epithelial Keratitis.

Authors:  Anny M S Cheng; Scheffer C G Tseng
Journal:  Cornea       Date:  2017-11       Impact factor: 2.651

6.  Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group.

Authors:  K R Wilhelmus; C R Dawson; B A Barron; P Bacchetti; L Gee; D B Jones; H E Kaufman; J Sugar; R A Hyndiuk; P R Laibson; R D Stulting; P A Asbell
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

7.  Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration.

Authors:  L M Collum; P McGettrick; J Akhtar; J Lavin; P J Rees
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

8.  Antiviral selection in the management of acute retinal necrosis.

Authors:  Patrick M K Tam; Claire Y Hooper; Susan Lightman
Journal:  Clin Ophthalmol       Date:  2010-02-02

Review 9.  Rational acyclovir therapy in herpetic eye disease.

Authors:  M G Falcon
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

Review 10.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.